A PRESCRIPTION drug company has emerged from its second bankruptcy in three years. Mallinckrodt, a generic drug maker, recently announced FDA approval of several new ready-for-market products as the maker turns a corner from its bankruptcy. GettyMallinckrodt, a prescription drug maker, exited bankruptcy[/caption] The company severely reduced its debt load in court. In court filings, the drug maker said it reduced its debts by $1.9 billion. The company said the bankruptcy advancement allows it to carry forward with new products. “Mallinckrodt has emerged from this process as a stronger company,” The company’s CEO, Siggi Olafsson, said in a statement. “We are moving
Hence then, the article about major pharmaceutical company emerges from second bankruptcy as ceo sites renewed energy from expanded product line was published today ( ) and is available onThe U.S. Sun ( Middle East ) The editorial team at PressBee has edited and verified it, and it may have been modified, fully republished, or quoted. You can read and follow the updates of this news or article from its original source.
Read More Details Finally We wish PressBee provided you with enough information of ( Major pharmaceutical company emerges from second bankruptcy as CEO sites ‘renewed energy’ from expanded product line )